Mechanism of action of Sini powder in treatment of liver cancer based on network pharmacology and molecular docking
DOI:10.3969/j.issn.1001-5256.2020.09.018
- VernacularTitle:基于网络药理学与分子对接研究四逆散治疗肝癌的作用机制
- Author:
Jing LI
1
;
Jiahao MO
;
Hongbin XU
;
Junxia ZHU
;
Peiyu SHI
;
Wanli XING
;
Chong ZHONG
;
Lizhu LIN
Author Information
1. The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510000, China
- Publication Type:Research Article
- Keywords:
Sini powders;
liver neoplasms;
molecular docking simulation;
network pharmacology
- From:
Journal of Clinical Hepatology
2020;36(9):1998-2004
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the mechanism of action of Sini powder in the treatment of liver cancer based on network pharmacology and molecular docking. MethodsTraditional Chinese Medicine Systems Pharmacology Database and Analysis Platform was used to obtain the compound and target of Sini powder, and the corresponding gene Symbol was obtained through Uniprot. The disease genes of liver cancer were obtained from Human Genome Database, and the genes with intersection with the target genes of Sini powder were screened out. Cytoscape3.7.1 software was used to draw the map of “traditional Chinese medicine (TCM)-compound-target” network. STRING was used to construct a protein-protein interaction (PPI) network, R studio software was used to conduct gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses on therapeutic targets, and then the results were visualized. The active component with the highest number of targets was selected as the ligand, and the target with the highest degree in the PPI network was selected as the receptor, so as to predict the structure of receptor-ligand complex and the amino acid residues that bind to each other. ResultsIn this study, 91 core targets and 141 relevant active components of Sini powder were screened out, among which quercetin and kaempferol were the main active components in the treatment of liver cancer. TP53 and HSP90AA1 were the main therapeutic targets. The GO enrichment analysis obtained 1007 items which met the screening criteria, which were mainly involved in the biological processes of antioxidation reaction, activity regulation of protein serine and threonine kinase, and cellular stress response. The KEGG enrichment analysis obtained 102 pathways, which mainly regulated the hepatitis B pathway and the PI3K-Akt signaling pathway in the prevention and treatment of liver cancer. The results of molecular docking showed a synergistic antitumor effect between the crystal structure domains VAL147, CYS220, GLU221, and PRO222 of quercetin-TP53. ConclusionThis study reveals the mechanism of action of Sini powder in the treatment of liver cancer by acting on multiple targets and signaling pathways, which provides a theoretical basis for biological experiments.
